Type
. Look to the bones for clues to human disease. Lancet (London, England). 2000;355(9211):1248.
Type
. [Leprosy and its cutaneous and neurologic manifestations]. Revue medicale de Liege. 2000;55(6):577-80.
Type
. Mycobacterial infection. The Malaysian journal of pathology. 1996;18(1):17-9.
Type
. [Epitheliomatous degeneration of wounds, ulcers and perforating plantar disorders in patients with leprosy]. Acta leprologica. 1978;(73):29-38.
Type
. Drug sensitivity of M. leprae isolated from leprosy patients administered DDS for long period of time. Acta leprologica. 1978;(73):13-28.
Type
. A preliminary report on a study of serum alpha-1-antitrypsin and immunoglobulin levels in lepromatous leprosy. Leprosy review [Internet]. 1976;47(4):291-4. Available from: http://leprev.ilsl.br/pdfs/1976/v47n4/pdf/v47n4a05.pdf
Type
. Plasma factors in delayed-type hypersensitivity. Augmentation of lymphocyte responses in borderline leprosy reactions. Clinical and experimental immunology [Internet]. 1976;26(3):397-402. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1540990/pdf/clinexpimmunol00244-0025.pdf
Type
. Immunologic responses in patients with lepromatous leprosy. Archives of dermatology. 1976;112(6):791-800.
Type
. [Lymphocyte transformation test in patients with leprosy. Its significance as an indicator of cellular immunity]. Bulletin de la Societe medicale d'Afrique noire de langue francaise. 1976;21(4):419-24.
Type
Experimental chemotherapy in leprosy. Bulletin of the World Health Organization [Internet]. 1976;53(4):425-33. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2366517/pdf/bullwho00460-0118.pdf
Pagination
- Previous page
- Page 1564
- Next page